• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

How to handle low-molecular-weight heparins in patients with decreased renal function: an open issue.

作者信息

Netti Giuseppe Stefano, Margaglione Maurizio, Gesualdo Loreto

机构信息

Department of Biomedical Sciences, Section of Nephrology, University of Foggia, Foggia, Italy.

出版信息

Intern Emerg Med. 2008 Dec;3(4):307-9. doi: 10.1007/s11739-008-0195-2. Epub 2008 Sep 20.

DOI:10.1007/s11739-008-0195-2
PMID:18807147
Abstract
摘要

相似文献

1
How to handle low-molecular-weight heparins in patients with decreased renal function: an open issue.如何处理肾功能减退患者的低分子量肝素：一个悬而未决的问题。
Intern Emerg Med. 2008 Dec;3(4):307-9. doi: 10.1007/s11739-008-0195-2. Epub 2008 Sep 20.
2
[Acute renal insufficiency caused by bilateral arterial thrombosis in a patient undergoing heparin treatment].[一名接受肝素治疗的患者双侧动脉血栓形成导致急性肾功能不全]
Nefrologia. 2002;22(4):394-5.
3
Clinical uses of low-molecular-weight heparins.
Chest. 1999 May;115(5):1418-23. doi: 10.1378/chest.115.5.1418.
4
Low-molecular-weight heparin in the treatment of pulmonary embolism.低分子量肝素治疗肺栓塞
Semin Vasc Surg. 2000 Sep;13(3):189-93.
5
Low molecular weight heparin and bleeding in patients with chronic renal failure.低分子量肝素与慢性肾衰竭患者的出血
Curr Opin Pulm Med. 2007 Sep;13(5):409-13. doi: 10.1097/MCP.0b013e328216430d.
6
Clinical and economic impact of low-molecular weight heparins in managed care. Introduction.
Am J Manag Care. 2000 Nov;6(20 Suppl):S1024-5.
7
[Mobile right atrial thrombus complicated by severe pulmonary embolism treated with low molecular weight heparin].
Tunis Med. 2003;81 Suppl 8:670-4.
8
Low molecular weight heparins and glomerular filtration rate: a report to be considered.低分子肝素和肾小球滤过率：一份需要考虑的报告。
Curr Vasc Pharmacol. 2011 Nov;9(6):693-7. doi: 10.2174/157016111797484170.
9
[Role of low molecular weight heparins for treating non-massive pulmonary embolism].
Presse Med. 1994 Dec 10;23(39):1821-5.
10
[Low molecular weight heparins: mechanisms of action and pharmococynetics. Clinical advantages over the classic unfractioned heparins].[低分子量肝素：作用机制与药代动力学。相较于传统普通肝素的临床优势]
Rev Port Cir Cardiotorac Vasc. 2003 Apr-Jun;10(2):61-7.

本文引用的文献

1
Low-molecular-weight heparin in patients with chronic renal insufficiency.慢性肾功能不全患者使用低分子量肝素。
Intern Emerg Med. 2008 Dec;3(4):319-23. doi: 10.1007/s11739-008-0164-9. Epub 2008 Jun 18.
2
Venous thromboembolism in patients with renal insufficiency: findings from the RIETE Registry.肾功能不全患者的静脉血栓栓塞症：RIETE注册研究的结果
Am J Med. 2006 Dec;119(12):1073-9. doi: 10.1016/j.amjmed.2006.04.028.
3
Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency.
荟萃分析：低分子量肝素与严重肾功能不全患者的出血情况
Ann Intern Med. 2006 May 2;144(9):673-84. doi: 10.7326/0003-4819-144-9-200605020-00011.
4
Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism.固定剂量皮下注射低分子量肝素与调整剂量普通肝素用于静脉血栓栓塞症的比较
Cochrane Database Syst Rev. 2004 Oct 18(4):CD001100. doi: 10.1002/14651858.CD001100.pub2.
5
Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.肝素与低分子量肝素：第七届抗栓与溶栓治疗ACCP会议
Chest. 2004 Sep;126(3 Suppl):188S-203S. doi: 10.1378/chest.126.3_suppl.188S.
6
Projecting the United States ESRD population: issues regarding treatment of patients with ESRD.预测美国终末期肾病患者数量：关于终末期肾病患者治疗的问题。
Kidney Int Suppl. 2004 Sep(90):S3-7. doi: 10.1111/j.1523-1755.2004.09002.x.
7
Anticoagulation in hospitalized patients with renal insufficiency: a comparison of bleeding rates with unfractionated heparin vs enoxaparin.肾功能不全住院患者的抗凝治疗：普通肝素与依诺肝素出血率的比较
Chest. 2004 Mar;125(3):856-63. doi: 10.1378/chest.125.3.856.
8
Correlation of antifactor Xa concentrations with renal function in patients on enoxaparin.依诺肝素治疗患者中抗Xa因子浓度与肾功能的相关性
J Clin Pharmacol. 2003 Jun;43(6):586-90.
9
Low-molecular-weight heparins: are they all the same?
Br J Haematol. 2003 Apr;121(1):12-20. doi: 10.1046/j.1365-2141.2003.04196.x.
10
Is impaired renal function a contraindication to the use of low-molecular-weight heparin?肾功能受损是使用低分子量肝素的禁忌症吗？
Arch Intern Med. 2002;162(22):2605-9. doi: 10.1001/archinte.162.22.2605.